This study was conducted by Hai Fang and his team from Peking University and published in Human Vaccines & Immunotherapeutics. The study evaluated the cost-effectiveness of using non-immunization program vaccines as an alternative to current vaccination strategies and simulated the economic and health consequences of meningococcal disease using four vaccination strategies based on the 2019 birth cohort. The result showed that using quadrivalent polysaccharide vaccine (MPV-4), bivalent conjugate vaccine (MCV-AC), and quadrivalent conjugate vaccine (MCV-4) could have increased health benefits but at a higher cost. The new strategies would be cost-effective provided lowering vaccine price.
Independent and joint associations of sex and birth order with non‑national immunization program vaccine coverage among Chinese children: a cross-sectional analysis
This research conducted by Prof. Xiaolin Xu and team from Zhejiang University, was published in the International Journal for Equity in Health. Based on a 2022 survey in Zhejiang and Henan provinces, the study analyzed the independent and joint associations of sex and birth order with non-National Immunization Program (non-NIP) vaccine coverage among Chinese children aged 1–6. The results showed that birth order was an important factor influencing vaccination, with the lowest coverage observed among later-born girls, particularly third or later-born daughters.
